A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol — Stella

Recruiting

Back to COVID-19 Infection trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(2 sites)

Canada

Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia

Health Sciences Centre, Hamilton, Ontario

Key details

Phase

Safety & dosing

Sponsor

McMaster University

Collaborators

Canadian Institutes of Health Research (CIHR)

Enrollment target

~350 participants

Started

March 2025

Primary completion

December 2026

Age range

18 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov